AAPS Gateway 2012: Vetter - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

AAPS Gateway 2012: Vetter


In Europe, contact:
Vetter Pharma International GmbH
Eywiesenstrasse 5
88212 Ravensburg, Germany
Phone: +49 (0)751 3700-0
info@vetter-pharma.com

In the U.S., contact:
Vetter Pharma International USA Inc.
Illinois Science + Technology Park
4901 Searle Parkway, Suite 300A
Skokie, IL 60077
USA
Phone: 847.581.6888
infoUS@vetter-pharma.com

Vetter is a leading contract development and manufacturing organization (CDMO) that specializes in the aseptic filling of syringes, cartridges and vials. The company has extensive experience with biologics and other complex compounds, including monoclonal antibodies, peptides, interferons and vaccines. Collaborating with pharma/biotech clients worldwide, Vetter supports products from preclinical development through global market supply. The company offers state-of-the-art technology and innovative processes to promote product quality and maximize API yield. Vetter’s Chicago facility, an expansion of Vetter Development Service, manufactures early-stage clinical products, with seamless transfer at Phase III to Vetter’s commercial manufacturing facilities.

Vetter now offers expanded clinical development services in US and Europe! Learn more at AAPS Annual Meeting 2012 in Chicago at Booth #5020.

 

Vetter Corporate Brochure

Vetter Development Service Brochure

Vetter Packaging Solutions Brochure

Press release: Vetter expands its capacities and services for prefilled syringes

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
Which of the following business challenge poses the greatest threat to your company?
Building a sustainable pipeline of products
Attracting a skilled workforce
Obtaining/maintaining adequate financing
Regulatory compliance
Building a sustainable pipeline of products
22%
Attracting a skilled workforce
30%
Obtaining/maintaining adequate financing
11%
Regulatory compliance
37%
View Results
Eric Langer Outsourcing Outlook Eric LangerBiopharma Outsourcing Activities Update
Cynthia Challener, PhD Ingredients Insider Cynthia Challener, PhDAppropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs
Jill Wechsler Regulatory Watch Jill Wechsler FDA and Manufacturers Seek a More Secure Drug Supply Chain
Sean Milmo European Regulatory WatcchSean MilmoQuality by Design?Bridging the Gap between Concept and Implementation
Medicare Payment Data Raises Questions About Drug Costs
FDA Wants You!
A New Strategy to Tackle Antibiotic Resistance
Drug-Diagnostic Development Stymied by Payer Concerns
Obama Administration Halts Attack on Medicare Drug Plans

Click here